TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals 
Thailand Inflation Remains Negative for 10th Straight Month in January 
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility 
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target 
Toshiba Corp Chairman Osamu Nagayama and another board member failed to get shareholder approval for their reappointments, as nine of the other candidates were approved.
Nagayama was under pressure to resign after an independent investigation revealed that Toshiba officials colluded with the Japanese government to control foreign investors’ influence.
Major shareholders and investment fund Effissimo alleged that Toshiba didn't fairly carry out Effissimo's nomination of dissident directors.
They demanded Nagayama's ouster as the latter has the most responsibility in nominating candidates and on the board's behavior.
Besides Effissimo, which owns a 10 percent stake in Toshiba, other foreign investors include Harvard University’s endowment fund and 3D Investment Partners.
Nagayama had vowed to restore transparency, get to the bottom of what happened, and prevent a recurrence.
In an open letter to shareholders, Nagayama sought backing for his reappointment, pledging to be an agent of positive change rather than as a protector of the status quo.
